A newly identified complex of genes called BRCC appears to work with the BRCA1 and BRCA2 genes, which, when mutated, are associated with an increased risk of developing breast and ovarian cancers. Researchers find that BRCC is overactive in more than half of the breast cancer tumors they examined.
